INTEGUMENT-INFANT: A Phase 2, 4-Week, Open-Label Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years with Atopic Dermatitis Hebert, A et al.

Arcutis Announces Publication Of Positive Data From INTEGUMENT-PED Trial Evaluating ZORYVE February 24, 2025 — 11:27 am EST Written by RTTNews.com for RTTNews -> ...

“Results from the INTEGUMENT-PED trial demonstrate that ZORYVE cream 0.05% can quickly and reliably improve the symptoms of AD, especially itch.

Study met the primary endpoint and all secondary endpoints, highly consistent with rapid response from the INTEGUMENT-1 and INTEGUMENT-2 pivotal trialsFor the primary endpoint, 25.4% of children ...

The INTEGUMENT-1 trial (ClinicalTrials.gov Identifier: NCT04773587) enrolled 654 patients 6 years of age and older with mild to moderate atopic dermatitis involving at least 3% body surface area.

Scales are formed by folds of the integument. Raised and depressed areas appear in the integument. Each bump consists of epidermis with the dermis underneath it and is known as a papilla. The papilli ...

The INTEGUMENT-2 trial (ClinicalTrials.gov Identifier: NCT04773600) included 683 patients 6 years of age and older with mild to moderate atopic dermatitis involving at least 3% body surface area.

A selective regime favoring a streamlining of body contours and surfaces is proposed as having been instrumental in driving the morphological and functional transformations of an unfeathered reptilian ...

The Society for the Study of Amphibians and Reptiles (SSAR) is a not-for-profit organization established to advance research, conservation, and education concerning amphibians and reptiles. It was ...

Integument Technologies continues its advancement in the chemical industry by partnering with UB to access its wealth of knowledge, laboratories and testing facilities. Today, Integument utilizes ...